nodes	percent_of_prediction	percent_of_DWPC	metapath
Adefovir Dipivoxil—SLC22A6—Captopril—systemic scleroderma	0.186	0.401	CbGbCtD
Adefovir Dipivoxil—ABCC4—Methotrexate—systemic scleroderma	0.135	0.291	CbGbCtD
Adefovir Dipivoxil—SLC22A8—Methotrexate—systemic scleroderma	0.0841	0.182	CbGbCtD
Adefovir Dipivoxil—SLC22A6—Methotrexate—systemic scleroderma	0.0586	0.127	CbGbCtD
Adefovir Dipivoxil—NME1—connective tissue—systemic scleroderma	0.00661	0.0948	CbGeAlD
Adefovir Dipivoxil—NME1—skin of body—systemic scleroderma	0.00597	0.0856	CbGeAlD
Adefovir Dipivoxil—AK2—tendon—systemic scleroderma	0.00592	0.0849	CbGeAlD
Adefovir Dipivoxil—AK2—lung—systemic scleroderma	0.00519	0.0745	CbGeAlD
Adefovir Dipivoxil—NME1—Fluticasone Propionate—Mometasone—systemic scleroderma	0.00497	1	CbGdCrCtD
Adefovir Dipivoxil—NME1—digestive system—systemic scleroderma	0.00477	0.0685	CbGeAlD
Adefovir Dipivoxil—AK4—digestive system—systemic scleroderma	0.0046	0.066	CbGeAlD
Adefovir Dipivoxil—NME2—digestive system—systemic scleroderma	0.0045	0.0645	CbGeAlD
Adefovir Dipivoxil—AK4—tendon—systemic scleroderma	0.00438	0.0628	CbGeAlD
Adefovir Dipivoxil—NME1—lung—systemic scleroderma	0.00399	0.0572	CbGeAlD
Adefovir Dipivoxil—AK4—lung—systemic scleroderma	0.00384	0.0551	CbGeAlD
Adefovir Dipivoxil—NME2—lung—systemic scleroderma	0.00375	0.0538	CbGeAlD
Adefovir Dipivoxil—SLC22A3—connective tissue—systemic scleroderma	0.00258	0.0371	CbGeAlD
Adefovir Dipivoxil—ABCC5—tendon—systemic scleroderma	0.00248	0.0356	CbGeAlD
Adefovir Dipivoxil—SLC22A3—smooth muscle tissue—systemic scleroderma	0.00236	0.0339	CbGeAlD
Adefovir Dipivoxil—ABCC5—lung—systemic scleroderma	0.00218	0.0313	CbGeAlD
Adefovir Dipivoxil—ABCC4—digestive system—systemic scleroderma	0.00181	0.026	CbGeAlD
Adefovir Dipivoxil—ABCC4—tendon—systemic scleroderma	0.00172	0.0247	CbGeAlD
Adefovir Dipivoxil—SLC22A3—lung—systemic scleroderma	0.00156	0.0224	CbGeAlD
Adefovir Dipivoxil—ABCC4—lung—systemic scleroderma	0.00151	0.0217	CbGeAlD
Adefovir Dipivoxil—Anorexia—Mometasone—systemic scleroderma	0.00145	0.00313	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Mycophenolic acid—systemic scleroderma	0.00145	0.00312	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Lisinopril—systemic scleroderma	0.00144	0.00312	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00144	0.00311	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Mycophenolate mofetil—systemic scleroderma	0.00142	0.00308	CcSEcCtD
Adefovir Dipivoxil—Cough—Captopril—systemic scleroderma	0.00142	0.00308	CcSEcCtD
Adefovir Dipivoxil—Haematuria—Lisinopril—systemic scleroderma	0.00141	0.00305	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Lisinopril—systemic scleroderma	0.0014	0.00302	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Captopril—systemic scleroderma	0.00139	0.003	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Captopril—systemic scleroderma	0.00139	0.003	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Pentoxifylline—systemic scleroderma	0.00139	0.003	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00139	0.003	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Lisinopril—systemic scleroderma	0.00139	0.003	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.00138	0.00299	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Leflunomide—systemic scleroderma	0.00135	0.00291	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Mometasone—systemic scleroderma	0.00133	0.00289	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Lisinopril—systemic scleroderma	0.00133	0.00287	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Leflunomide—systemic scleroderma	0.00133	0.00287	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Mometasone—systemic scleroderma	0.00132	0.00285	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Lisinopril—systemic scleroderma	0.00132	0.00285	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Azathioprine—systemic scleroderma	0.00132	0.00285	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Mycophenolate mofetil—systemic scleroderma	0.00131	0.00284	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Lisinopril—systemic scleroderma	0.00131	0.00283	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Captopril—systemic scleroderma	0.0013	0.00282	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Lisinopril—systemic scleroderma	0.0013	0.00281	CcSEcCtD
Adefovir Dipivoxil—Back pain—Leflunomide—systemic scleroderma	0.0013	0.00281	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Mycophenolic acid—systemic scleroderma	0.00128	0.00277	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Mycophenolate mofetil—systemic scleroderma	0.00127	0.00275	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Captopril—systemic scleroderma	0.00127	0.00275	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Mycophenolic acid—systemic scleroderma	0.00126	0.00273	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.00126	0.00273	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Pentoxifylline—systemic scleroderma	0.00126	0.00273	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Pentoxifylline—systemic scleroderma	0.00124	0.00269	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Leflunomide—systemic scleroderma	0.00124	0.00269	CcSEcCtD
Adefovir Dipivoxil—Back pain—Mycophenolic acid—systemic scleroderma	0.00124	0.00268	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00124	0.00268	CcSEcCtD
Adefovir Dipivoxil—Haematuria—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00267	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Mycophenolate mofetil—systemic scleroderma	0.00123	0.00265	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Mycophenolate mofetil—systemic scleroderma	0.00122	0.00263	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.00121	0.00262	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Azathioprine—systemic scleroderma	0.00121	0.00262	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.0012	0.0026	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Pentoxifylline—systemic scleroderma	0.0012	0.0026	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Mometasone—systemic scleroderma	0.0012	0.00259	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Mometasone—systemic scleroderma	0.0012	0.00259	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Mycophenolic acid—systemic scleroderma	0.00119	0.00256	CcSEcCtD
Adefovir Dipivoxil—Cough—Leflunomide—systemic scleroderma	0.00117	0.00254	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Captopril—systemic scleroderma	0.00117	0.00253	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.00116	0.00252	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Captopril—systemic scleroderma	0.00116	0.0025	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Lisinopril—systemic scleroderma	0.00116	0.0025	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Mycophenolate mofetil—systemic scleroderma	0.00115	0.0025	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00248	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Leflunomide—systemic scleroderma	0.00115	0.00248	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Leflunomide—systemic scleroderma	0.00115	0.00248	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00247	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00247	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Lisinopril—systemic scleroderma	0.00114	0.00246	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00114	0.00246	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00114	0.00246	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Azathioprine—systemic scleroderma	0.00113	0.00244	CcSEcCtD
Adefovir Dipivoxil—Cough—Mycophenolic acid—systemic scleroderma	0.00112	0.00242	CcSEcCtD
Adefovir Dipivoxil—Back pain—Lisinopril—systemic scleroderma	0.00112	0.00242	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Pentoxifylline—systemic scleroderma	0.00112	0.00242	CcSEcCtD
Adefovir Dipivoxil—Rash—Pentoxifylline—systemic scleroderma	0.00111	0.0024	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Pentoxifylline—systemic scleroderma	0.00111	0.00239	CcSEcCtD
Adefovir Dipivoxil—Headache—Pentoxifylline—systemic scleroderma	0.0011	0.00238	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Mycophenolic acid—systemic scleroderma	0.00109	0.00236	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Mycophenolic acid—systemic scleroderma	0.00109	0.00236	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Captopril—systemic scleroderma	0.00109	0.00235	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Mometasone—systemic scleroderma	0.00109	0.00235	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00108	0.00235	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Leflunomide—systemic scleroderma	0.00108	0.00233	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00107	0.00232	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Mometasone—systemic scleroderma	0.00107	0.00232	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Lisinopril—systemic scleroderma	0.00107	0.00231	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Leflunomide—systemic scleroderma	0.00107	0.00231	CcSEcCtD
Adefovir Dipivoxil—Hepatic failure—Methotrexate—systemic scleroderma	0.00106	0.00229	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00106	0.00229	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Captopril—systemic scleroderma	0.00105	0.00228	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Captopril—systemic scleroderma	0.00105	0.00228	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Leflunomide—systemic scleroderma	0.00105	0.00226	CcSEcCtD
Adefovir Dipivoxil—Nausea—Pentoxifylline—systemic scleroderma	0.00104	0.00226	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Mometasone—systemic scleroderma	0.00104	0.00224	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00103	0.00222	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00103	0.00222	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00102	0.0022	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00219	CcSEcCtD
Adefovir Dipivoxil—Cough—Lisinopril—systemic scleroderma	0.00101	0.00218	CcSEcCtD
Adefovir Dipivoxil—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.00101	0.00217	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.001	0.00217	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.001	0.00216	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Mycophenolic acid—systemic scleroderma	0.000998	0.00216	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000998	0.00216	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Lisinopril—systemic scleroderma	0.000984	0.00213	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Lisinopril—systemic scleroderma	0.000984	0.00213	CcSEcCtD
Adefovir Dipivoxil—Back pain—Mycophenolate mofetil—systemic scleroderma	0.00098	0.00212	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000977	0.00211	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Leflunomide—systemic scleroderma	0.000966	0.00209	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Prednisone—systemic scleroderma	0.000966	0.00209	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Mometasone—systemic scleroderma	0.000964	0.00208	CcSEcCtD
Adefovir Dipivoxil—Rash—Mometasone—systemic scleroderma	0.000956	0.00207	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Captopril—systemic scleroderma	0.000956	0.00207	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Mometasone—systemic scleroderma	0.000955	0.00207	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Leflunomide—systemic scleroderma	0.000954	0.00206	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000954	0.00206	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000951	0.00206	CcSEcCtD
Adefovir Dipivoxil—Headache—Mometasone—systemic scleroderma	0.00095	0.00205	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000948	0.00205	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Captopril—systemic scleroderma	0.000942	0.00204	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000936	0.00202	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000924	0.002	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000922	0.00199	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Azathioprine—systemic scleroderma	0.000919	0.00199	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Azathioprine—systemic scleroderma	0.000919	0.00199	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Lisinopril—systemic scleroderma	0.000916	0.00198	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Captopril—systemic scleroderma	0.000911	0.00197	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00091	0.00197	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000904	0.00195	CcSEcCtD
Adefovir Dipivoxil—Nausea—Mometasone—systemic scleroderma	0.000901	0.00195	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Lisinopril—systemic scleroderma	0.000899	0.00194	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000898	0.00194	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Prednisone—systemic scleroderma	0.000891	0.00193	CcSEcCtD
Adefovir Dipivoxil—Cough—Mycophenolate mofetil—systemic scleroderma	0.000884	0.00191	CcSEcCtD
Adefovir Dipivoxil—Liver function test abnormal—Methotrexate—systemic scleroderma	0.00088	0.0019	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Leflunomide—systemic scleroderma	0.000868	0.00188	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Leflunomide—systemic scleroderma	0.000868	0.00188	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000862	0.00186	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000862	0.00186	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000859	0.00186	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000856	0.00185	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000856	0.00185	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Captopril—systemic scleroderma	0.000847	0.00183	CcSEcCtD
Adefovir Dipivoxil—Rash—Captopril—systemic scleroderma	0.00084	0.00182	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Captopril—systemic scleroderma	0.000839	0.00181	CcSEcCtD
Adefovir Dipivoxil—Headache—Captopril—systemic scleroderma	0.000834	0.0018	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Lisinopril—systemic scleroderma	0.00083	0.0018	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000828	0.00179	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000828	0.00179	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Lisinopril—systemic scleroderma	0.00082	0.00177	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000814	0.00176	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000811	0.00175	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000809	0.00175	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Methotrexate—systemic scleroderma	0.000807	0.00175	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000803	0.00174	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Azathioprine—systemic scleroderma	0.000795	0.00172	CcSEcCtD
Adefovir Dipivoxil—Nausea—Captopril—systemic scleroderma	0.000791	0.00171	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000788	0.0017	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Leflunomide—systemic scleroderma	0.000788	0.0017	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Leflunomide—systemic scleroderma	0.000777	0.00168	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Prednisone—systemic scleroderma	0.000775	0.00168	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000771	0.00167	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000753	0.00163	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Mycophenolic acid—systemic scleroderma	0.000751	0.00162	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Leflunomide—systemic scleroderma	0.000751	0.00162	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Lisinopril—systemic scleroderma	0.000746	0.00161	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Lisinopril—systemic scleroderma	0.000746	0.00161	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Mycophenolic acid—systemic scleroderma	0.000741	0.0016	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Azathioprine—systemic scleroderma	0.000739	0.0016	CcSEcCtD
Adefovir Dipivoxil—Rash—Azathioprine—systemic scleroderma	0.000733	0.00158	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Azathioprine—systemic scleroderma	0.000732	0.00158	CcSEcCtD
Adefovir Dipivoxil—Headache—Azathioprine—systemic scleroderma	0.000728	0.00157	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000728	0.00157	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Methotrexate—systemic scleroderma	0.000722	0.00156	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000718	0.00155	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000717	0.00155	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000714	0.00154	CcSEcCtD
Adefovir Dipivoxil—Haematuria—Methotrexate—systemic scleroderma	0.0007	0.00151	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Leflunomide—systemic scleroderma	0.000698	0.00151	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000694	0.0015	CcSEcCtD
Adefovir Dipivoxil—Rash—Leflunomide—systemic scleroderma	0.000692	0.0015	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Leflunomide—systemic scleroderma	0.000692	0.0015	CcSEcCtD
Adefovir Dipivoxil—Nausea—Azathioprine—systemic scleroderma	0.000691	0.00149	CcSEcCtD
Adefovir Dipivoxil—Headache—Leflunomide—systemic scleroderma	0.000688	0.00149	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Prednisone—systemic scleroderma	0.000686	0.00148	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Lisinopril—systemic scleroderma	0.000677	0.00146	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000676	0.00146	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Lisinopril—systemic scleroderma	0.000667	0.00144	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Mycophenolic acid—systemic scleroderma	0.000666	0.00144	CcSEcCtD
Adefovir Dipivoxil—Rash—Mycophenolic acid—systemic scleroderma	0.00066	0.00143	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00066	0.00143	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Methotrexate—systemic scleroderma	0.000659	0.00142	CcSEcCtD
Adefovir Dipivoxil—Headache—Mycophenolic acid—systemic scleroderma	0.000656	0.00142	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Methotrexate—systemic scleroderma	0.000654	0.00141	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000653	0.00141	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000653	0.00141	CcSEcCtD
Adefovir Dipivoxil—Nausea—Leflunomide—systemic scleroderma	0.000652	0.00141	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000651	0.00141	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Methotrexate—systemic scleroderma	0.000646	0.0014	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Lisinopril—systemic scleroderma	0.000645	0.0014	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Prednisone—systemic scleroderma	0.000634	0.00137	CcSEcCtD
Adefovir Dipivoxil—Nausea—Mycophenolic acid—systemic scleroderma	0.000622	0.00134	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Lisinopril—systemic scleroderma	0.0006	0.0013	CcSEcCtD
Adefovir Dipivoxil—Rash—Lisinopril—systemic scleroderma	0.000595	0.00129	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Lisinopril—systemic scleroderma	0.000594	0.00128	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000593	0.00128	CcSEcCtD
Adefovir Dipivoxil—Headache—Lisinopril—systemic scleroderma	0.000591	0.00128	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000585	0.00126	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Prednisone—systemic scleroderma	0.000584	0.00126	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.00058	0.00125	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Methotrexate—systemic scleroderma	0.000574	0.00124	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000566	0.00122	CcSEcCtD
Adefovir Dipivoxil—Nausea—Lisinopril—systemic scleroderma	0.00056	0.00121	CcSEcCtD
Adefovir Dipivoxil—Back pain—Methotrexate—systemic scleroderma	0.000555	0.0012	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Prednisone—systemic scleroderma	0.000549	0.00119	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Prednisone—systemic scleroderma	0.000544	0.00118	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Prednisone—systemic scleroderma	0.000534	0.00115	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Methotrexate—systemic scleroderma	0.00053	0.00115	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000526	0.00114	CcSEcCtD
Adefovir Dipivoxil—Rash—Mycophenolate mofetil—systemic scleroderma	0.000521	0.00113	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000521	0.00113	CcSEcCtD
Adefovir Dipivoxil—Headache—Mycophenolate mofetil—systemic scleroderma	0.000518	0.00112	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00051	0.0011	CcSEcCtD
Adefovir Dipivoxil—Cough—Methotrexate—systemic scleroderma	0.000501	0.00108	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Prednisone—systemic scleroderma	0.000493	0.00107	CcSEcCtD
Adefovir Dipivoxil—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000491	0.00106	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Methotrexate—systemic scleroderma	0.000488	0.00106	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Methotrexate—systemic scleroderma	0.000488	0.00106	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Prednisone—systemic scleroderma	0.000487	0.00105	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000485	0.00105	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Methotrexate—systemic scleroderma	0.000459	0.000993	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000458	0.000991	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000458	0.00099	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Methotrexate—systemic scleroderma	0.000455	0.000983	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Methotrexate—systemic scleroderma	0.000446	0.000965	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Prednisone—systemic scleroderma	0.000443	0.000958	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Prednisone—systemic scleroderma	0.000443	0.000958	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000427	0.000922	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Methotrexate—systemic scleroderma	0.000412	0.000891	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Methotrexate—systemic scleroderma	0.000407	0.00088	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000404	0.000874	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Prednisone—systemic scleroderma	0.000402	0.000869	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Prednisone—systemic scleroderma	0.000396	0.000857	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Prednisone—systemic scleroderma	0.000383	0.000829	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000383	0.000828	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Methotrexate—systemic scleroderma	0.00037	0.0008	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Methotrexate—systemic scleroderma	0.00037	0.0008	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Prednisone—systemic scleroderma	0.000356	0.00077	CcSEcCtD
Adefovir Dipivoxil—Rash—Prednisone—systemic scleroderma	0.000353	0.000764	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Prednisone—systemic scleroderma	0.000353	0.000763	CcSEcCtD
Adefovir Dipivoxil—Headache—Prednisone—systemic scleroderma	0.000351	0.000759	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Methotrexate—systemic scleroderma	0.000336	0.000726	CcSEcCtD
Adefovir Dipivoxil—Nausea—Prednisone—systemic scleroderma	0.000333	0.000719	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Methotrexate—systemic scleroderma	0.000331	0.000716	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Methotrexate—systemic scleroderma	0.00032	0.000693	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Methotrexate—systemic scleroderma	0.000298	0.000644	CcSEcCtD
Adefovir Dipivoxil—Rash—Methotrexate—systemic scleroderma	0.000295	0.000638	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Methotrexate—systemic scleroderma	0.000295	0.000638	CcSEcCtD
Adefovir Dipivoxil—Headache—Methotrexate—systemic scleroderma	0.000293	0.000634	CcSEcCtD
Adefovir Dipivoxil—Nausea—Methotrexate—systemic scleroderma	0.000278	0.000601	CcSEcCtD
